CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Net Inc. Y/Y Annual
Zynex inc   (ZYXI)
Other Ticker:  
 
 

ZYXI's Net Income Growth by Quarter and Year

Zynex Inc 's Net Income results by quarter and year




ZYXI Net Income (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 1.22 7.45 8.89
III Quarter September - 3.59 4.87 6.11
II Quarter June 1.22 3.35 3.35 2.81
I Quarter March 0.01 1.57 1.38 -0.71
FY   1.23 9.73 17.05 17.10



ZYXI Net Income second quarter 2024 Y/Y Growth Comment
Zynex Inc reported drop in Net Income in the second quarter 2024 by -63.67% to $ 1.22 millions, from the same quarter in 2023.
The fall in the second quarter 2024 Zynex Inc 's Net Income compares unfavorably to the Company's average Net Income doubling of 458.56%.

Looking into second quarter 2024 results within Medical Equipment & Supplies industry 18 other companies have achieved higher Net Income growth. While Zynex Inc ' s Net Income meltdown of -63.67% ranks overall at the positon no. 651 in the second quarter 2024.


ZYXI Net Income ( Y/Y Growth %) 2024
 2023 2022 2021
IV Quarter December - -83.62 % -16.2 % 396.65 %
III Quarter September - -26.28 % -20.29 % 359.4 %
II Quarter June -63.67 % 0 % 19.22 % -6.95 %
I Quarter March -99.36 % 13.77 % - -
FY   - -42.93 % -0.29 % 88.33 %

Financial Statements
Zynex Inc 's second quarter 2024 Net Income $ 1.22 millions ZYXI's Income Statement
Zynex Inc 's second quarter 2023 Net Income $ 3.35 millions Quarterly ZYXI's Income Statement
New: More ZYXI's historic Net Income Growth >>


ZYXI Net Income (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
IV Quarter December - -66.02 % 52.98 % 45.5 %
III Quarter September - 7.16 % 45.37 % 117.44 %
II Quarter June 12070 % 113.38 % 142.75 % -
I Quarter March -99.18 % -78.93 % -84.48 % -
FY (Year on Year)   - -42.93 % -0.29 % 88.33 %


Compare ZYXI Profitability >> Back to ZYXI Growth rate Comparisons >>


Net Income second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #19
Healthcare Sector #53
Overall #651

Net Income Y/Y Growth Statistics
High Average Low
10573.91 % 458.56 % -65 %
(Dec 31 2017)   (Jun 30 2024)
Net Income second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #19
Healthcare Sector #53
Overall #651
Net Income Y/Y Growth Statistics
High Average Low
10573.91 % 458.56 % -65 %
(Dec 31 2017)   (Jun 30 2024)

Net Income by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Zynex Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
12070 % 426 % -99.18 %
(Jun 30 2024)  


ZYXI's II. Quarter Q/Q Net Income Comment
Zynex inc achieved in the II. Quarter 2024 above company average sequential Net Income doubling of 12070%, to $ 1.22 millions, from $0.01 millions in the first quarter.
ZYXI is impressively improving, with reporting higher then average gain, and also improving speed.

Within Medical Equipment & Supplies industry Zynex inc achieved highest sequential Net Income growth. While Zynex Inc 's Net Income growth quarter on quarter, overall rank is 4.


Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #0
Healthcare Sector #1
Overall #4
Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #0
Healthcare Sector #1
Overall #4
Net Income Q/Q Growth Statistics
High Average Low
12070 % 426 % -99.18 %
(Jun 30 2024)  


ZYXI's II. Quarter Q/Q Net Income Comment
Zynex inc achieved in the II. Quarter 2024 above company average sequential Net Income doubling of 12070%, to $ 1.22 millions, from $0.01 millions in the first quarter.
ZYXI is impressively improving, not just recording higher then normal increase, but also increasing pace, Chloe  Brown, Healthcare sector researcher said.

Within Medical Equipment & Supplies industry Zynex inc achieved highest sequential Net Income growth. While Zynex Inc 's Net Income growth quarter on quarter, overall rank is 4.


Zynex Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)		 12 Months Ending
(Jun 30 2023)
Cumulative Net Income 12 Months Ending $ 6.04 $ 8.17 $ 9.73 $ 15.97 $ 17.25
Y / Y Net Income Growth (TTM) -65 % -52.59 % -42.91 % -13.63 % -12.55 %
Year on Year Net Income Growth Overall Ranking # 764 # 853 # 723 # 278 # 12
Seqeuential Net Income Change (TTM) -26.15 % -16.02 % -39.06 % -7.42 % 0.05 %
Seq. Net Income Growth (TTM) Overall Ranking # 651 # 711 # 823 # 1101 # 195

New: More ZYXI's historic Net Income Growth >>



Cumulative Net Income growth Comment
Zynex Inc 's cumulative 12 months Net Income continue to drop, but on the faster rate at -65% year on year, at Jun 30 2024 compare to the -52.59% decrease at Mar 31 2024. If the Zynex Inc 's fiscal year would end at Jun 30 2024, annual Net Income would be $6 millions.

In the Healthcare sector 58 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 764, from total ranking in previous quarter at 853.

Net Income TTM Q/Q Growth Statistics
High Average Low
10573.91 %
458.56 %
-65 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 19
Healthcare Sector # 59
Overall # 764

Net Income TTM Y/Y Growth Statistics
High Average Low
10573.91 %
458.56 %
-65 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 19
Sector # 53
S&P 500 # 651
Cumulative Net Income growth Comment
Zynex Inc 's cumulative 12 months Net Income continue to drop, but on the faster rate at -65% year on year, at Jun 30 2024 compare to the -52.59% decrease at Mar 31 2024. If the Zynex Inc 's fiscal year would end at Jun 30 2024, annual Net Income would be $6 millions.

In the Healthcare sector 58 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 764, from total ranking in previous quarter at 853.

Net Income TTM Q/Q Growth Statistics
High Average Low
10573.91 %
458.56 %
-65 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 19
Healthcare Sector # 59
Overall # 764

Net Income TTM Y/Y Growth Statistics
High Average Low
10573.91 %
458.56 %
-65 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 19
Sector # 53
S&P 500 # 651




Other Net Income Growth
Medical Equipment & Supplies Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
ZYXI's Net Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for ZYXI's Competitors
Net Income Growth for Zynex Inc 's Suppliers
Net Income Growth for ZYXI's Customers

You may also want to know
ZYXI's Annual Growth Rates ZYXI's Profitability Ratios ZYXI's Asset Turnover Ratio ZYXI's Dividend Growth
ZYXI's Roe ZYXI's Valuation Ratios ZYXI's Financial Strength Ratios ZYXI's Dividend Payout Ratio
ZYXI's Roa ZYXI's Inventory Turnover Ratio ZYXI's Growth Rates ZYXI's Dividend Comparisons



Companies with similar Net Income drop for the quarter ending Jun 30 2024 within Healthcare SectorY/Y Change %Net Income for the quarter ending Jun 30 2024
Biogen Inc -1.63%$ -1.635 millions
Embecta Corp -3.29%$ -3.289 millions
Quest Diagnostics Inc-3.61%$ -3.614 millions
Abbott Laboratories-5.31%$ -5.309 millions
Zoetis Inc -6.87%$ -6.866 millions
Idexx Laboratories Inc-9.34%$ -9.337 millions
Prestige Consumer Healthcare Inc -11.89%$ -11.893 millions
Align Technology inc -13.64%$ -13.639 millions
National Research Corporation-15.10%$ -15.097 millions
Dariohealth Corp -17.94%$ -17.938 millions
Bristol myers Squibb Company-18.92%$ -18.922 millions
Organon and Co -19.42%$ -19.421 millions
U S Physical Therapy Inc-21.21%$ -21.206 millions
Pacira Biosciences inc -26.69%$ -26.693 millions
Privia Health Group Inc -27.00%$ -26.997 millions
West Pharmaceutical Services Inc -28.24%$ -28.240 millions
Neurocrine Biosciences Inc -31.94%$ -31.937 millions
Abbvie Inc -32.26%$ -32.264 millions
Lifevantage Corp-33.62%$ -33.622 millions
Lantheus Holdings Inc -34.06%$ -34.057 millions
Viemed Healthcare Inc -36.61%$ -36.609 millions
Vaso Corporation-44.26%$ -44.257 millions
Nature s Sunshine Products inc -44.42%$ -44.415 millions
Royalty Pharma Plc-44.67%$ -44.675 millions
Globus Medical Inc -44.97%$ -44.968 millions
Amgen Inc -45.90%$ -45.903 millions
Surgery Partners Inc -50.78%$ -50.780 millions
Radnet Inc -52.29%$ -52.294 millions
Option Care Health Inc -53.63%$ -53.635 millions
Pro dex Inc -58.30%$ -58.303 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com